GO
Loading...

U.S. Regulators OK Generic Version Of Ambien Sleeping Pill

CNBC.com
Monday, 23 Apr 2007 | 1:35 PM ET

Mylan Laboratories said U.S. regulators approved its generic version of Sanofi-Aventis' sleeping pill, Ambien, in the 5 mg and 10 mg strengths.

In a statement, the generic drug maker said the product is being shipped immediately.

Ambien had sales of about $2.2 billion in the U.S. for the same strengths for the 12-month period ending Dec. 31, 2006, according to IMS Health.

Sanofi-Aventis lost patent protection for Ambien on April 21. Ambien dominates the U.S. sleeping pill market, which is growing at about 10% a year.

  Price   Change %Change
MYL
---
SNI
---

Featured

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • CNBC's Scott Cohn reports from Boston on marathon security detail and the cities ongoing efforts to heal from last year's bombings. Cohn also discusses the claims fund being administered by Ken Feinberg.

  • Jon Steinberg, BuzzFeed president & COO, weighs in on Airbnb's $10 billion valuation and the company's recent $500 million round of funding.

  • Jon Steinberg, BuzzFeed president & COO, discusses if he thinks Netflix will provide an earnings hit amid mounting competition from Amazon and why the stock is so pricey.